Who owns IMA?
Institutional ownership of ImageneBio Inc. from Form 13F, Q2 2026
35 institutional managers reported holding ImageneBio Inc. (IMA) in Form 13F filings for Q2 2026, with 6,234,663 shares worth $36.8M. The largest reported holder was BVF Inc. Managers that filed both quarters added a net 878,868 shares (+16.4%). 5 opened new positions and 8 sold out.
- Funds holding
- 35
- Value held
- $36.8M
- New / sold out
- 5 / 8
- Net shares, same filers
- +16.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IMA
Share of 13F holdings is each fund's shares as a share of the 6,234,663 IMA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Orbimed Advisors LLC Added+$3.1M
- Trails Edge Capital Partners, LP New+$1.7M
- Monashee Investment Management LLC New+$1.1M
- Cable Car Capital, LP Added+$158K
- Nano Cap New Millennium Growth Fund L P Added+$118K
- Two Sigma Investments, LP New+$117K
- Northern Trust Corp New+$66K
- BlackRock, Inc. Added+$35K
- Renaissance Technologies LLC Added+$31K
- Goldman Sachs Group Inc Added+$24K
Biggest sellers in Q2 2026
- Citadel Advisors LLC Trimmed-$406K
- Blue Owl Capital Holdings LP Trimmed-$246K
- Jacobs Levy Equity Management, Inc Sold out-$133K
- XTX Topco Ltd Sold out-$76K
- Rangeley Capital, LLC Trimmed-$74K
- HRT Financial LP Sold out-$69K
- Jane Street Group, LLC Sold out-$66K
- Prelude Capital Management, LLC Sold out-$65K
- Geode Capital Management, LLC Trimmed-$38K
- Vanguard Capital Management LLC Trimmed-$27K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $6.5M and sold $1.2M; 9 added and 12 trimmed.
Schedule 13D and 13G filings on IMA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-04-21Omega Fund VI, L.P. SCHEDULE 13D filed by ImageneBio Inc.Schedule 13D
- 2025-06-16BML Investment Partners, L.P. SCHEDULE 13D filed by Ikena Oncology Inc.Schedule 13D
- 2024-12-31BML Investment Partners, L.P. SCHEDULE 13G filed by Ikena Oncology Inc.Schedule 13G
Questions about IMA ownership
- Who owns IMA stock?
- 35 institutional investment managers reported IMA positions in their Form 13F filings for Q2 2026, holding 6,234,663 shares worth $36.8M in total. BVF Inc reported the largest position.
- Are funds buying or selling IMA?
- In Q2 2026, 5 managers opened new IMA positions, 9 added, 12 trimmed and 8 sold out. Managers that filed in both quarters added a net 878,868 shares.
- How current is this IMA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IMA by CUSIP. Options are left out. IMA news and filings · IMA insider trades · Top funds